AAIPharma Services, Cambridge Major Laboratories Name Executive VP - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AAIPharma Services, Cambridge Major Laboratories Name Executive VP



AAIPharma Services, a provider of pharmaceutical analytical testing, product development, and manufacturing services, and Cambridge Major Laboratories, a provider of pharmaceutical API development and manufacturing, have appointed Jeff Yuen as executive vice-president, global quality. Yuen has served as food and drug investigator at the State of California’s, Department of Health Services and was a Commander in the US Public Health Service at FDA. He also was GMP auditor, GMP advisor or FDA advisory committee member at National Nutritional Foods Association, Dietary Supplement, and BIOCOM. After leaving the FDA, he led an independent firm focused on FDA compliance and regulatory consulting for the dietary supplement, pharmaceutical, and biotechnology industries.

Source:AAIPharma Services

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications

Click here